Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.22.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Revenues:    
Total revenues $ 33,161 $ 28,991
Cost of Revenues:    
Total cost of revenue 18,762 14,521
Gross profit 14,399 14,470
Operating expenses:    
Selling, general and administrative expenses 14,912 13,608
Research and development expenses 3,229 2,745
Total Operating expenses 18,141 16,353
Income (loss) from operations (3,742) (1,883)
Interest income 13 12
Interest expense 100 557
Other (expense) income, net (1)
Net loss before income taxes (3,630) (1,314)
Income tax benefit (expense) 703 (473)
Net loss before non-controlling interest (2,927) (1,787)
Non-controlling interest (1)
Net loss (2,928) (1,787)
Accretion of preferred stock (168) (168)
Preferred stock dividend (1,028) (1,028)
Net loss attributable to common stockholders $ (4,124) $ (2,983)
Net loss per share attributable to common stockholders - basic and diluted $ (0.12) $ (0.09)
Weighted average common shares outstanding - basic and diluted 35,332 33,259
Product [Member]    
Revenues:    
Total revenues $ 14,392 $ 11,420
Cost of Revenues:    
Total cost of revenue 11,978 8,152
Service [Member]    
Revenues:    
Total revenues 18,769 17,571
Cost of Revenues:    
Total cost of revenue $ 6,784 $ 6,369